gimli

SAIPARENT stock AI analysis

SAIPARENT Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

SAI PARENTERALS LIMITED is a small-cap stock in Healthcare. This Gimli page shows the latest available SAIPARENT price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive SAIPARENT stock page

Price

₹469.25

1W return

-1.88%

1M return

-10.39%

3M return

-15.38%

6M return

-3.46%

1Y return

n/a

Market cap

₹2,073.11 cr

105.61

9.42

ROE

+19.63%

ROCE

+16.99%

RSI

43.05

Turnover

₹9.74 cr

Why it can matter in screens

Momentum: SAIPARENT is below 50DMA, below 200DMA; RSI is 43.05.
Returns: 1D -2.38%, 1W -1.88%, 1M -10.39%, 3M -15.38%, 1Y n/a.
Trend levels: 52W high ₹706.00, 52W low ₹441.35, off high -33.53%.
Liquidity: latest turnover is ₹9.74 cr; volume vs 20D is +1.19%.
Valuation/profitability: PE 105.61, PB 9.42, ROE +19.63%, ROCE +16.99%.
Growth: 3Y sales CAGR n/a, 3Y profit CAGR n/a.

Quick Answers

What is the latest SAIPARENT stock price?

The latest stored price for SAIPARENT is Rs 469.25 as of 2026-11-03.

Is SAIPARENT above its 50DMA and 200DMA?

SAIPARENT is below 50DMA, below 200DMA. The latest 50DMA is 505.86 and the latest 200DMA is n/a.

What are SAIPARENT PE, ROE and ROCE?

SAIPARENT has PE 105.61, ROE +19.63%, and ROCE +16.99% in Gimli's latest available snapshot.

How has SAIPARENT performed recently?

SAIPARENT has returned -10.39% over 1 month, -15.38% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-06-30	178.67 cr	27.26 cr	15.85 cr	1.79
2025-09-30	269.12 cr	28.82 cr	-1.18 cr	nan
2025-06-30	33.39 cr	5.92 cr	2.83 cr	0.64

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2025-03-31	494.96 cr	54.35 cr	19.63 cr	4.44
2024-03-31	153.76 cr	33.10 cr	8.41 cr	1.90
2023-03-31	96.80 cr	18.77 cr	4.38 cr	0.99

Balance sheet

Period	Assets	Cash	Debt	Equity
2025-03-31	723.58 cr	8.15 cr	203.66 cr	123.61 cr
2024-03-31	268.10 cr	4.38 cr	118.78 cr	76.40 cr
2023-03-31	133.96 cr	0.17 cr	68.55 cr	31.48 cr

Cash flow

Period	OCF	FCF	Cash change
2025-03-31	33.15 cr	32.65 cr	n/a
2024-03-31	-29.76 cr	-73.86 cr	n/a
2023-03-31	-12.80 cr	-30.14 cr	n/a

Shareholding Trend

Period	Promoter	FII/FPI	DII	MF	Retail	Pledge
2026-06-30	+51.16%	+4.03%	+8.53%	+0.98%	+36.29%	+0.00%
2026-04-01	+51.16%	+5.73%	+12.86%	+3.81%	+30.26%	+0.00%
2026-03-31	+51.16%	+5.73%	+12.86%	+3.81%	+30.26%	+0.00%

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	424,658.30 cr	35.053345	+15.50%	+3.72%
DIVISLAB	DIVI S LABORATORIES LTD	267,167.60 cr	91.684145	+18.37%	+47.91%
TORNTPHARM	TORRENT PHARMACEUTICALS L	157,377.11 cr	74.094685	+16.87%	+28.16%
LAURUSLABS	LAURUS LABS LIMITED	125,408.69 cr	114.827348	+21.77%	+138.16%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	124,833.39 cr	27.818646	+16.04%	+26.46%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	121,354.29 cr	57.614911	+22.62%	+7.87%
DRREDDY	DR. REDDY S LABORATORIES	113,923.95 cr	40.698752	+7.80%	+14.41%
CIPLA	CIPLA LTD	112,841.65 cr	38.950805	+8.80%	-7.58%

Try these prompts

Analyze SAI PARENTERALS with valuation, momentum and industry peers
Compare SAIPARENT with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-11-03. Not investment advice.